Daiichi Sankyo withdraws application for rapid approval of lung cancer treatment drug in the US
第一三共、米国で肺がん治療薬の迅速承認の申請取り下げ
Reports
- 第一三共、米国で肺がん治療薬の迅速承認の申請取り下げDaiichi Sankyo withdraws application for rapid approval of lung cancer treatment drug in the USassets.wor.jp · ja ·